MDNA Life Sciences Inc. (MDLS)

MDNA Life Sciences Cash Flow Statement

Financials in millions USD. Fiscal year is October - September.

Year Ending	TTM	Sep 30, 2021	Sep 30, 2020
Net Income	-3	-3.79	-5.29
Depreciation & Amortization	0.64	0.64	0.58
Share-Based Compensation	0	0	0
Other Operating Activities	1.8	1.8	2.61
Operating Cash Flow	-0.56	-0.56	-1.38
Capital Expenditures	-0.06	-0.06	-0.25
Investing Cash Flow	-0.06	-0.06	-0.25
Debt Issued / Paid	1.85	1.85	1.08
Other Financing Activities	-0.32	-0.32	-0.08
Financing Cash Flow	1.53	1.53	1
Net Cash Flow	0.91	0.91	-0.61
Free Cash Flow	-0.62	-0.62	-1.63
Free Cash Flow Margin	-17.25%	-17.25%	-1536.33%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).